View in EDS HTML Full Text PDF Full Text

Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.
Authors: Zhang L; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Hao X; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Cui Y; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Yan W; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Shang K; College of Pharmacy, Changchun University of Chinese Medicine, Changchun, China., Zhang X; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.
Source: Frontiers in medicine [Front Med (Lausanne)] 2026 Jun 11; Vol. 13, pp. 1806488. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026).
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42369158
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Hao+X%22">Hao X</searchLink>; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Cui+Y%22">Cui Y</searchLink>; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Yan+W%22">Yan W</searchLink>; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Shang+K%22">Shang K</searchLink>; College of Pharmacy, Changchun University of Chinese Medicine, Changchun, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101648047%22">Frontiers in medicine</searchLink> [Front Med (Lausanne)] 2026 Jun 11; Vol. 13, pp. 1806488. <i>Date of Electronic Publication: </i>2026 Jun 11 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101648047 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2296-858X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222296858X%22">2296858X </searchLink><i>NLM ISO Abbreviation: </i>Front Med (Lausanne) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42369158
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fmed.2026.1806488
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1806488
    Titles:
      – TitleFull: Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Hao X
      – PersonEntity:
          Name:
            NameFull: Cui Y
      – PersonEntity:
          Name:
            NameFull: Yan W
      – PersonEntity:
          Name:
            NameFull: Shang K
      – PersonEntity:
          Name:
            NameFull: Zhang X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 06
              Text: 2026 Jun 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2296-858X
          Numbering:
            – Type: volume
              Value: 13
          Titles:
            – TitleFull: Frontiers in medicine
              Type: main
ResultId 1